European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee

[1]  C. Patrono,et al.  Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen? , 1996, Stroke.

[2]  C. Loeb,et al.  European Stroke Prevention Study 2: Baseline data , 1995, Journal of the Neurological Sciences.

[3]  Radcliffe Infirmary,et al.  Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients , 1994, BMJ.

[4]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[5]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[6]  Ruth Bonita,et al.  Epidemiology of stroke , 1992, The Lancet.

[7]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[8]  M. Laakso,et al.  The European Stroke Prevention Study , 1991, Neurology.

[9]  L. Wilkins.  European Stroke Prevention Study. ESPS Group. , 1990, Stroke.

[10]  T. Müller,et al.  Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo. , 1990, British journal of clinical pharmacology.

[11]  H. Adams,et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.

[12]  V. Hachinski,et al.  THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE , 1989, The Lancet.

[13]  U. Förstermann,et al.  Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP. , 1989, European journal of pharmacology.

[14]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[15]  L. Wilkins.  Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group. , 1985 .

[16]  P. Touboul,et al.  "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. , 1983, Stroke.

[17]  Rupert G. Miller,et al.  Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.

[18]  R. Hardy,et al.  Controlled Trial of Aspirin in Cerebral Ischemia , 1977, Stroke.